Evaluation of fracture risk and potential drug holidays for postmenopausal women on long-term bisphosphonate therapy
Matthew D Kostoff, Joseph J Saseen, Laura M BorgeltDepartments of Clinical Pharmacy and Family Medicine, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences and School of Medicine, Aurora, CO, USAStudy objective: To describe characteristics of postmenopausal women on long-te...
Saved in:
Main Authors: | Kostoff MD (Author), Saseen JJ (Author), Borgelt LM (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2014-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis
by: Michael Pazianas, et al.
Published: (2010) -
Bisphosphonate drug holidays: Can we recommend currently?
by: Vishal R Tandon, et al.
Published: (2014) -
Long-term Treatment with Bisphosphonates and Their Side Effects in Postmenopausal Osteoporosis - Review
by: Merih Sarıdoğan, et al.
Published: (2010) -
Bilateral Femoral Diaphyseal Fractures After Long-Term Bisphosphonates Therapy: A Case Report
by: Fatma Ustabaşıoğlu, et al.
Published: (2012) -
Can bone turnover markers help to define the suitability and duration of bisphosphonate drug holidays?
by: Louise Statham, et al.
Published: (2020)